Apimeds Pharmaceuticals US (APUS) Files for 3.33M Share IPO at $3-$4/sh
Apimeds Pharmaceuticals US (NYSE: APUS) has filed for 3,333,334 share IPO at $3-$4 per share.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Royal Caribbean to acquire 50% stake in Sandals Resorts for $3 billion
- Societe Generale SA (GLE:FP) (SCGLY) PT Raised to EUR83 at JPMorgan
- Raymond James Downgrades Baldwin Insurance (BWIN) to Underperform
Create E-mail Alert Related Categories
Corporate News, IPOsRelated Entities
IPO, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share